EcoDrugPlus

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSOMYG00000024692
Gene Symbol: GSK3B
1 Cross references
171 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSOMYG00000002509
Gene Symbol: GSK3B
1 Cross references
170 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSOMYG00000014612
Gene Symbol: GSK3B
1 Cross references
213 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSOMYG00000015722
Gene Symbol: GSK3B
2 Cross references
213 Possible Orthologues:

Growth Hormone Secretagogue Receptor 1a

Ensembl ID : ENSOMYG00000020530
Gene Symbol: GHS-R
3 Cross references
207 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSOMYG00000010457
Gene Symbol: GUCY1A1
1 Cross references
195 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSOMYG00000041145
Gene Symbol: GUCY1A1
1 Cross references
195 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSOMYG00000040230
Gene Symbol: GUCY1A2
1 Cross references
197 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSOMYG00000041152
Gene Symbol: GUCY1B1
1 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSOMYG00000010367
Gene Symbol: GUCY1B1
1 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1, Soluble, Alpha 2

Ensembl ID : ENSOMYG00000040916
Gene Symbol: GUCY1A2
1 Cross references
196 Possible Orthologues:

Heat Shock 90kda Protein 1 Beta Isoform B

Ensembl ID : ENSOMYG00000002804
Gene Symbol: HSP90BB
2 Cross references
333 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).